ArticleACS medicinal chemistry letters2019

PROTAC Degradation of IRAK4 for the Treatment of Neurodegenerative and Cardiovascular Diseases.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.